UIM
NVCR icon

USS Investment Management’s NovoCure NVCR Stock Holding History

USS Investment Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,912
Closed -$481K – 668
2022
Q2 		$481K Sell
6,912
-1,316
-16% -$99.1K ﹤0.01% 682
2022
Q1 		$682K Sell
8,228
-12,128
-60% -$893K 0.01% 688
2021
Q4 		$1.53M Hold
20,356
– – 0.01% 665
2021
Q3 		$2.36M Buy
+20,356
New +$3.08M 0.02% 603

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

USS Investment Management's NVCR Position: Q3 2022 in Review

USS Investment Management sold out of NovoCure (NVCR) in Q3 2022, closing a stake of 6,912 shares — an estimated $481K sold.

USS Investment Management first reported a position in NVCR in Q3 2021 and held it in 4 quarters. The position peaked at $2.36M in Q3 2021. 303 funds tracked by Wall St. Rank hold NVCR as of Q3 2022.

  • USS Investment Management reported no remaining NovoCure position as of Q3 2022 after selling out during the quarter.
  • USS Investment Management sold 6,912 NovoCure shares in Q3 2022, an estimated $481K.
  • USS Investment Management first reported a position in NovoCure in Q3 2021 and held it in 4 quarters.
  • USS Investment Management's NovoCure position peaked at $2.36M in Q3 2021.
  • 303 funds tracked by Wall St. Rank held NovoCure as of Q3 2022.

Based on USS Investment Management's 13F filing for Q3 2022, filed 8 Nov 2022.